From the Society of Nuclear Medicine meeting exhibit floor, an audio interview with Karthik Kuppusamy, Ph.D., general manger for Americas nuclear medicine, PET/CT, and cyclotron business at GE Healthcare, who touted the company’s Discovery VCT.
At this year's Society of Nuclear Medicine meeting, cardiac PET is emerging from the long shadow of PET/CT for oncology applications. Rejuvenated by increased Medicare reimbursements for perfusion that began this year, PET is also reaping the benefits of a growing body of research supporting its use.
On the SNM exhibit floor, Karthik Kuppusamy, Ph.D., general manger for Americas nuclear medicine, PET/CT, and cyclotron business at GE Healthcare, touted the company's Discovery VCT. The device combines 64-slice CT and high resolution PET as a one-stop shop for assessment of suspected cardiovascular disease. Discovery VCT delivers analyses of ventricular function, wall motion, and perfusion, as well as coronary CT angiograms and calcium scoring, in less than 30 minutes.
But rest and stress imaging using the Discovery VCT to identify perfusion defects presents special challenges that require the deft use of CT during pharmaceutical stress - and a special algorithm developed by GE.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.